Respiratory Infections

International collaboration, fast action, and mRNA platform technology led to phase 3 trials in record time—without compromise of safety standards.

The agency requested data this week, following the pause of large-scale international assessment after a non-fatal serious adverse event was reported in a UK participant earlier this month.

The country is split on certain strategies and a potential vaccine. Here's why the message needs to go from national to regional.

The test provides qualitative detection of nucleic acid from SARS-CoV-2 in oral saline rinse specimens, nasopharyngeal swab, and nasal swab specimens in a universal transport media, as well as nasal swabs collected in oral saline rinse.

Brad Spellberg, MD, describes the inconsistent, impersonal messaging given to the public as cases begin to rise again.

From acute kidney injury to children with ADHD, here's the latest research and discussions around the pandemic's effect on other specialties.

Stanford investigators suggest the findings could continually represent an accurate estimate of US antibody accrual.

An interview with a Harvard-based researcher on troubling associations between RDW and hospitalized COVID-19 patients' mortality risks.

New international analysis highlights successes—and shortcomings—among Pacific Asia and European regions who began to reopen their societies.

The EUA grants clinicians and caregivers capability to provide serologic assay results in person to potentially infected patients.

Is it still safe to take your child to get a vaccine during the pandemic? According to experts, there are safety measures in place for this critically important task.

J&J is evaluating both 1- and 2-dose regimens of the adenovirus vector investigational vaccine.

Dr. Debra Goff describes the rush to "Just in Case" prescribing of antibiotics early in the COVID-19 pandemic, when less was known about the clinical course of the disease.

Rheumatologists are understandably concerned regarding immune suppressed patients amid the coronavirus (COVID-19) pandemic. What are the risk factors for hospitalization? And do drugs which act against inflammation complicate matters?

On Friday, new guidelines from CDC sought to show how the pandemic coronavirus (COVID-19) spreads. By Monday, those guidelines changed.

Dr. Shervin Molayem, DDS, continues our discussion on his recent paper The Mouth-COVID Connection: Il-6 Levels in Periodontal Disease — Potential Role in COVID-19-Related Respiratory Complications.

The country successfully managed thousands of mild cases among foreign construction workers at the height of the pandemic through an isolation facility. It may not be an applicable model, though.

What the AstraZeneca vaccine research pause meant for physician-patient discussion on vaccine candidate safety.

Do the norms of media coverage of SARS-CoV-2 worsen rising acute stress and depressive symptoms in the United States?

The guidance clarification published today comes just a day after reports a polarizing guidance was published last month without full review nor consensus from the agency.

Antibodies are just one part of the body's immune response. And growing evidence suggests many of us could already have cross-reactive cellular immunity to the “novel” coronavirus.

Dr. Shervin Molayem, DDS, outlines his recent paper The Mouth-COVID Connection: Il-6 Levels in Periodontal Disease — Potential Role in COVID-19-Related Respiratory Complications.

Officials state the controversial August guidance was influenced by other federal agencies, and that revisions may come soon.

A health data analytics expert describes how repeat or low-value studies can arise amid the rush to publish pandemic research.

An editorial advocating a new method of CRISPR testing was published in NEJM by a team of scientists from MIT, University of Washington, and Brigham & Women’s Hospital.

MediFind's Patrick Howie examines the consolidation of resources during pandemics amid concerns that funding will not return to other areas of health research.

A look into the long-term implications of the virus on athletes' cardiovascular fitness.

What we've seen non-immunized communities do for previously eradicated outbreaks.

The logistics of supplying the vaccine are being handled by a collaboration of federal agencies. The DoD, parts of HHS, and CDC are coordinating supply, production, and distribution.

Lockdowns implemented for pandemic control have broad health, social, and economic consequences. This is especially true for people who live and work in slum communities around the world.